All the funding deals in the neurotechnology market
Last updated: 13 July 2026
Download our beautiful pitch about the neurotechnology market
In our neurotechnology market deck, you will find everything you need to understand the market
The neurotechnology market is attracting strong interest across brain-computer interfaces, neuromodulation, neurodiagnostics, and neural monitoring.
We conducted deep research and collected 83 neurotechnology market funding deals announced between 2024 and 2026.
We refresh this page very often to add new neurotechnology funding deals and update existing information.
And if you want to better understand this new industry, you should get our beautiful slides covering the neurotechnology market.
Insights
- The 83 neurotechnology market deals in this list represent more than $4.2 billion in disclosed funding between 2024 and 2026.
- Brain-computer interface companies received several of the largest rounds, including Neuralink at $650 million, BrainCo at $286.3 million, and Merge Labs at $252 million.
- The neurotechnology market is not limited to brain implants. Large rounds also supported spinal stimulation, migraine treatment, bladder care, chronic pain, and inflammatory diseases.
- Funding became more concentrated in 2025 and 2026. A small group of neurotechnology companies raised rounds above $100 million, while many early-stage companies stayed below $20 million.
- Non-invasive neurotechnology is gaining ground. Focused ultrasound, optical monitoring, wearable EEG, sensory stimulation, and portable magnetic stimulation all attracted new capital.
- Clinical applications remain the main funding driver in the neurotechnology market. Investors often supported products linked to paralysis, Parkinson’s disease, Alzheimer’s disease, epilepsy, depression, and chronic pain.
- Several neurotechnology companies raised money more than once during the period. Examples include ONWARD Medical, Beacon Biosignals, Neurable, Cognito Therapeutics, Rune Labs, and StairMed.
- Consumer neurotechnology remains smaller than clinical neurotechnology, but sleep headbands, cognitive wearables, stress devices, and brain-monitoring products continue to attract investors.
- The neurotechnology market has become increasingly global, with funded companies based across North America, Europe, Israel, China, India, Singapore, and Australia.
This chart, featured in our neurotechnology market deck, shows annual VC investment in neurotechnology startups
Summary table of the funding deals for the neurotechnology market since 2024
We define the neurotechnology market as products that directly measure, stimulate, or computationally interface with the human nervous system for clinical or validated functional outcomes.
We include neurodevices and their enabling software such as BCIs, neuromodulation systems, and neurodiagnostic/monitoring tools (e.g., EEG and related analytics).
We exclude pharmaceuticals, general-purpose imaging infrastructure not purpose-built for neuro, and standalone wellness or mental-health apps that do not directly capture or act on nervous-system signals.
We focused exclusively on pure players, defined as companies with at least 70–80% of their business directly tied to the neurotechnology market.
Our analysis has been done at a global level with a minimum funding threshold of $300k.
You can also read our detailed analysis to understand how funding activity in the neurotechnology market has evolved recently.
If you want a longer-term view, we also have a study of how funding activity in the neurotechnology market has changed over the years.
Also, you should know that we have a dedicated page, updated weekly, with all the latest fundraising deals in the neurotechnology market.
| Name | What they do | Amount in $ | Quarter | Source(s) |
|---|---|---|---|---|
| WISE | Develops implantable electrodes for neurostimulation and neural monitoring | $34.8M | Q2 2026 | BusinessWire |
| BCI-Sonics / Huachao Super Control | Develops an AI-powered ultrasound brain-computer interface | $14.0M | Q2 2026 | 36Kr |
| Neurosoft Bioelectronics | Develops soft implantable neural interfaces and neuroelectronic devices | $7.5M | Q2 2026 | BusinessWire |
| Axoft | Develops soft implantable brain-computer interfaces | $55.0M | Q2 2026 | BusinessWire |
| Nervonik | Develops neuromodulation therapy for inflammatory and autoimmune diseases | $52.5M | Q2 2026 | PR Newswire |
| Beacon Biosignals | Provides EEG analytics and neurobiomarkers for clinical trials and patient care | $11.0M | Q2 2026 | Beacon Biosignals |
| neuroClues | Develops eye-tracking tests for neurological disorder assessment | $10.8M | Q1 2026 | neuroClues |
| Mave Health | Develops non-invasive brain stimulation for mental health treatment | $2.1M | Q1 2026 | BusinessWire |
| Surf Therapeutics | Develops focused-ultrasound neuromodulation for movement disorders | $6.0M | Q1 2026 | BusinessWire |
| StairMed | Develops implantable brain-computer interfaces and neural technologies | $72.7M | Q1 2026 | Medical Device Network |
| Gestala | Develops glasses with brain-computer interface capabilities | $21.69M | Q1 2026 | Gestala |
| ANEUVO | Develops neuromodulation therapies for spinal cord injuries and paralysis | $22.0M | Q1 2026 | FinSMEs |
| Cognito Therapeutics | Develops sensory neuromodulation therapy for Alzheimer’s disease | $105.0M | Q1 2026 | BusinessWire |
| Science Corp | Develops retinal implants and advanced brain-computer interfaces | $230.0M | Q1 2026 | Science Corp |
| Temple | Develops an AI wearable for body and brain signal monitoring | $54.0M | Q1 2026 | TechCrunch |
| Neupulse | Develops wearable neuromodulation therapy for Tourette syndrome | $3.8M | Q1 2026 | Neupulse |
| Neurent Medical | Develops a neuromodulation device for chronic rhinitis | $74.0M | Q1 2026 | PR Newswire |
| neuropacs | Provides neuroimaging workflow and clinical neurology software | $1.0M | Q1 2026 | neuropacs |
| Merge Labs | Develops ultrasound-based brain-computer interface technology | $252.0M | Q1 2026 | WIRED |
| Enspire DBS Therapy | Develops deep-brain stimulation therapy for stroke recovery | $10.3M | Q1 2026 | PR Newswire |
| BrainCo | Develops non-invasive brain-computer interfaces and neural-controlled prosthetics | $286.3M | Q1 2026 | Yicai Global |
| Spiro Medical | Develops targeted lung-denervation neuromodulation for asthma | $67.0M | Q1 2026 | PR Newswire |
| Neurable | Develops non-invasive brain-computer interfaces for everyday wearable devices | $35.0M | Q4 2025 | BusinessWire |
| AI-Stroke | Uses smartphone video to identify possible strokes before hospital imaging | $4.6M | Q4 2025 | PR Newswire |
| Beacon Biosignals | Uses AI and EEG data to develop brain-health biomarkers | $86.0M | Q4 2025 | Beacon Biosignals |
| NextSense | Develops wireless in-ear EEG devices for sleep and cognitive monitoring | $16.0M | Q4 2025 | BusinessWire |
| Synchron | Develops an endovascular brain-computer interface for people with paralysis | $200.0M | Q4 2025 | BusinessWire |
| Coherence Neuro | Develops a closed-loop brain-computer interface for cancer treatment | $10.0M | Q4 2025 | MassDevice |
| ONWARD Medical | Develops spinal stimulation therapies for movement recovery after spinal cord injury | $58.1M | Q4 2025 | Euronext |
| Ampa | Develops portable magnetic brain stimulation for depression treatment | $8.5M | Q4 2025 | PR Newswire |
| Cala Health | Develops wearable neuromodulation therapy for hand tremor | $50.0M | Q4 2025 | BusinessWire |
| CoMind | Develops optical technology for non-invasive brain monitoring | $60.0M | Q4 2025 | CoMind |
| Neuronoff | Develops injectable peripheral nerve stimulation for chronic pain | $4.5M | Q4 2025 | PR Newswire |
| Boomerang Medical | Develops implantable neuromodulation therapy for inflammatory bowel disease | $20.0M | Q3 2025 | BusinessWire |
| SetPoint Medical | Develops implantable neuroimmune therapy for rheumatoid arthritis | $140.0M | Q3 2025 | SetPoint Medical |
| Nudge | Develops focused ultrasound for non-invasive brain stimulation and imaging | $100.0M | Q3 2025 | Nudge |
| Cumulus Neuroscience | Provides at-home EEG monitoring for neuroscience clinical trials | $4.4M | Q3 2025 | Tech.eu |
| Salvia BioElectronics | Develops implantable neuromodulation therapy for chronic migraine | $58.0M | Q2 2025 | GlobeNewswire |
| Phantom Neuro | Develops implantable neural interfaces for prosthetic and robotic control | $19.0M | Q2 2025 | PR Newswire |
| Spark Biomedical | Develops wearable neurostimulation therapies for pain and neurological conditions | $15.0M | Q2 2025 | Spark Biomedical |
| Somnee | Develops an EEG sleep headband with personalized neurostimulation | $10.0M | Q2 2025 | BusinessWire |
| Neuralink | Develops implantable brain-computer interfaces for digital device control | $650.0M | Q2 2025 | Neuralink |
| Rune Labs | Provides software for monitoring Parkinson’s disease using wearable and implant data | $11.2M | Q2 2025 | STAT News |
| Magnus Medical | Develops accelerated magnetic brain stimulation for treatment-resistant depression | $23.7M | Q2 2025 | FormDs |
| brain.space | Develops dry-EEG systems and standardized brain-data analytics | $11.0M | Q1 2025 | PR Newswire |
| Valencia Technologies | Develops an implanted tibial nerve stimulator for urinary incontinence | $35.0M | Q1 2025 | PR Newswire |
| Subsense | Develops a non-surgical nanoparticle-based brain-computer interface | $17.0M | Q1 2025 | BusinessWire |
| Newronika | Develops adaptive deep-brain stimulation for Parkinson’s disease | $14.7M | Q1 2025 | PR Newswire |
| Neuro Event Labs | Uses AI video analysis to detect and classify epileptic seizures | $2.2M | Q1 2025 | Neuro Event Labs |
| Echo Neurotechnologies | Develops brain interfaces that decode neural activity | $50.0M | Q1 2025 | Gaebler |
| Saluda Medical | Develops closed-loop spinal stimulation that adjusts therapy automatically | $100.0M | Q1 2025 | FinSMEs |
| Zeto | Develops wearable EEG devices and cloud-based diagnostic software | $31.0M | Q1 2025 | PR Newswire |
| BrainSightAI | Provides AI brain mapping for diagnosis and treatment planning | $5.0M | Q1 2025 | IAN Group |
| Cala Health | Develops wearable neuromodulation therapy for hand tremor | $50.0M | Q4 2024 | PR Newswire |
| Precision Neuroscience | Develops thin-film brain-computer interface implants for people with paralysis | $102.0M | Q4 2024 | Yahoo Finance |
| MintNeuro | Builds semiconductor chips for neural sensing and stimulation implants | $1.27M | Q4 2024 | PR Newswire |
| Nuuron | Develops retinal photonic neuromodulation therapy for Alzheimer’s disease | $3.8M | Q4 2024 | HTGF |
| INBRAIN Neuroelectronics | Develops graphene-based brain-computer interfaces and adaptive neural therapies | $50.0M | Q4 2024 | BusinessWire |
| ONWARD Medical | Develops spinal stimulation therapy for spinal cord injury recovery | $54.0M | Q4 2024 | Euronext |
| Ceribell | Provides rapid EEG systems and AI seizure detection for hospitals | $180.3M | Q4 2024 | Renaissance Capital |
| ShiraTronics | Develops implantable neurostimulation therapy for chronic migraine | $66.0M | Q4 2024 | PR Newswire |
| Neuspera Medical | Develops miniaturized implantable sacral neuromodulation systems | $23.0M | Q3 2024 | Neuspera Medical |
| Roga | Develops a wearable neurostimulation device for stress reduction | $1.2M | Q3 2024 | PRWeb |
| Insightec | Develops focused ultrasound systems for incisionless neurological treatment | $150.0M | Q2 2024 | Insightec |
| Omniscient Neurotechnology | Builds AI brain-mapping software for neurosurgical planning | $30.0M | Q2 2024 | Omniscient Neurotechnology |
| Amber Therapeutics | Develops adaptive implantable neuromodulation for urinary incontinence | $100.0M | Q2 2024 | BioSpace |
| Cognixion | Builds EEG and augmented-reality tools for assistive communication | $6.04M | Q2 2024 | BusinessWire |
| Oculogica | Develops eye-tracking tools for concussion and brain-health assessment | $11.6M | Q2 2024 | BusinessWire |
| Neurable | Builds EEG brain-computer interfaces for everyday devices and cognitive monitoring | $13.0M | Q2 2024 | BusinessWire |
| Blackrock Neurotech | Develops implantable brain-computer interfaces for communication and movement control | $200.0M | Q2 2024 | Blackrock Neurotech |
| ONWARD Medical | Develops spinal stimulation therapy for movement recovery after spinal cord injury | $21.6M | Q1 2024 | Euronext |
| SynPhNe | Develops EEG and muscle-sensing rehabilitation tools for stroke recovery | $5.0M | Q1 2024 | Business Times |
| Nalu Medical | Develops miniaturized nerve stimulation implants for chronic pain | $85.0M | Q1 2024 | Nalu Medical |
| Samphire Neuroscience | Develops a brain-stimulation wearable for PMS and menstrual pain | $2.3M | Q1 2024 | Tech Funding News |
| StairMed Technology | Develops implantable brain-computer interfaces and surgical tools | $48.0M | Q1 2024 | PR Newswire |
| Avation Medical | Develops wearable neuromodulation technology for bladder treatment | $22.0M | Q1 2024 | PR Newswire |
| Elemind | Develops an EEG headband that supports faster sleep onset | $12.0M | Q1 2024 | BusinessWire |
| SPR Therapeutics | Develops peripheral nerve stimulation systems for acute and chronic pain | $25.0M | Q1 2024 | BioSpace |
| Cognito Therapeutics | Develops light-and-sound neuromodulation therapy for Alzheimer’s disease | $35.0M | Q1 2024 | Axios |
| Motif Neurotech | Develops a wireless brain implant for treatment-resistant depression | $18.75M | Q1 2024 | BusinessWire |
| Noctrix Health | Develops wearable neurostimulation therapy for restless legs syndrome | $40.0M | Q1 2024 | PR Newswire |
| Rune Labs | Provides Parkinson’s monitoring software using wearable and implanted-device data | $12.0M | Q1 2024 | BusinessWire |
| Neuphony | Builds EEG headbands and neurofeedback tools for cognitive training | $1.96M | Q1 2024 | Business Standard |
This market map, featured in our neurotechnology market deck, highlights top companies and startups in the neurotechnology market
Related blog posts
- The latest update in the neurotechnology market
- The most recent news in the neurotechnology market
- How large is the neurotechnology market in reality?
- The most recent funding news in the neurotechnology market
- The main fundraising trends in the neurotechnology market
- The evolution of funding activity in the neurotechnology market
